scispace - formally typeset
M

Michael W. Shaw

Researcher at Rockefeller University

Publications -  7
Citations -  355

Michael W. Shaw is an academic researcher from Rockefeller University. The author has contributed to research in topics: Neuraminidase & Gene. The author has an hindex of 5, co-authored 7 publications receiving 354 citations.

Papers
More filters
Journal ArticleDOI

A previously unrecognized influenza B virus glycoprotein from a bicistronic mRNA that also encodes the viral neuraminidase

TL;DR: Sucrose gradient sedimentation and analysis of the structure of the mRNA by nuclease S1 mapping and sequence analysis by the primer extension method indicated that polypeptide NB and the neuraminidase are translated from a single bicistronic mRNA.
Journal ArticleDOI

Complete nucleotide sequence of the neuraminidase gene of influenza B virus

TL;DR: The complete nucleotide sequence of the neuraminidase gene of influenza virus B/Lee/40 was derived from a cloned cDNA copy of virion RNA segment 6 and its corresponding mRNA, which revealed seven regions of extensive homology within the central portion of the molecules.
Journal ArticleDOI

Segment-specific and common nucleotide sequences in the noncoding regions of influenza B virus genome RNAs.

TL;DR: Comparison of these data with published reports has revealed that some of the features found in the noncoding regions of influenza B virus are also present in influenza A and C virus RNAs.
Journal ArticleDOI

A specific sub-set of host-cell mRNAs prime influenza virus mRNA synthesis

TL;DR: Host RNA primers containing a 3'-terminal Py-G-C-A sequence before the presumed endonuclease cleavage site are preferred for use as primers in influenza virus mRNA synthesis, with some differences noted between the transcripts of types A and B influenza virus genome segments.
Journal ArticleDOI

Studies on the synthesis of the influenza b virus nb glycoprotein

TL;DR: The finding of polypeptides smaller than NB that exhibit a labeling pattern with different amino acids which is characteristic of NB and which are precipitated by the mouse antiviral serum suggests that specific cleavage products of NB may be formed in infected cells.